Scinopharm Taiwan Limited (1789):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Scinopharm Taiwan Limited (1789) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH183543FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical company. The company develops and manufactures APIs and intermediates for pharmaceutical industry. Its products include atazanavir sulfate, benazepril hydrochloride, docetaxel anhydrous, flavoxate hydrochloride, galantamine hydrobromide, granisetron hydrochloride, tamsulosin hydrochloride, ondansetron hydrochloride, irinotecan hydrochloride, irinotecan hydrochloride, fosaprepitant dimeglumine, lapatinib ditosylate and dantrolene sodium. ScinoPharm offers peptide synthesis technologies. The company’s services include analytical and regulatory services, chemical process development, exploratory process research and consulting services. It markets products through a network of distributors in Germany, Scandinavia, France and the US. The company has manufacturing facilities in China and Taiwan. ScinoPharm is headquartered in Shan Hua, Taiwan.

Scinopharm Taiwan Limited Key Recent Developments

Dec 12, 2013: ScinoPharm Completes Changshu, China Plant

This comprehensive SWOT profile of Scinopharm Taiwan Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Scinopharm Taiwan Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Scinopharm Taiwan Limited – Key Information
Scinopharm Taiwan Limited – Overview
Scinopharm Taiwan Limited – Key Employees
Scinopharm Taiwan Limited – Key Employee Biographies
Scinopharm Taiwan Limited – Key Operational Heads
Scinopharm Taiwan Limited – Major Products and Services
Scinopharm Taiwan Limited – History
Scinopharm Taiwan Limited – Company Statement
Scinopharm Taiwan Limited – Locations And Subsidiaries
Scinopharm Taiwan Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Scinopharm Taiwan Limited – Business Description
Scinopharm Taiwan Limited – Corporate Strategy
Scinopharm Taiwan Limited – SWOT Analysis
SWOT Analysis – Overview
Scinopharm Taiwan Limited – Strengths
Scinopharm Taiwan Limited – Weaknesses
Scinopharm Taiwan Limited – Opportunities
Scinopharm Taiwan Limited – Threats
Scinopharm Taiwan Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Scinopharm Taiwan Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Scinopharm Taiwan Limited, Key Information
Scinopharm Taiwan Limited, Key Ratios
Scinopharm Taiwan Limited, Share Data
Scinopharm Taiwan Limited, Major Products and Services
Scinopharm Taiwan Limited, History
Scinopharm Taiwan Limited, Key Employees
Scinopharm Taiwan Limited, Key Employee Biographies
Scinopharm Taiwan Limited, Key Operational Heads
Scinopharm Taiwan Limited, Other Locations
Scinopharm Taiwan Limited, Subsidiaries
Scinopharm Taiwan Limited, Key Manufacturing facilities
Scinopharm Taiwan Limited, Key Competitors
Scinopharm Taiwan Limited, SWOT Analysis
Scinopharm Taiwan Limited, Ratios based on current share price
Scinopharm Taiwan Limited, Annual Ratios
Scinopharm Taiwan Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Scinopharm Taiwan Limited, Performance Chart
Scinopharm Taiwan Limited, Ratio Charts

★海外企業調査レポート[Scinopharm Taiwan Limited (1789):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genable Technologies Limited(製薬・医療分野):企業M&A動向
    Summary Genable Technologies Limited (Genable) is a bio-pharmaceutical company. The company discovers, manufactures and distributes new gene therapies for the treatment of inherited genetic disorders. Its product GT038 is used for the treatment of patients with inherited blindness resulting from a d …
  • Cosmo Bio Co Ltd (3386):企業財務及び戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) is a medical device company that develops and markets research reagents and research instruments. The company provides reagents, research instruments and life science research biotools for biochemistry, such as sugars, lipids, lectins, hormones, peptides, amino a …
  • iZumi Bio, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iZumi Bio, Inc. Mergers and Acq …
  • The Fresh Market, Inc.:企業の戦略・SWOT・財務分析
    The Fresh Market, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Fresh Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Resonance Health Ltd (RHT):企業のM&A・提携動向(医療機器分野)
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider with focus on non-invasive medical imaging software and services. Its major products and services include FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* du …
  • Premier Inc (PINC):医療機器:M&Aディール及び事業提携情報
    Summary Premier Inc (Premier) is a provider of healthcare solutions. It is an alliance of hospitals, health systems, physicians and other healthcare providers in the US. The alliance enables the owners to share services and programs aimed at improving the quality and cost-effectiveness of clinical o …
  • First Niagara Risk Management, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' First Niagara Risk Management, …
  • BoneSupport AB:企業のM&A・提携動向(医療機器分野)
    Summary BoneSupport AB (BoneSupport) is a medical technology company with focus on injectable osteoconductive biomaterials. It develops, manufactures and markets injectable bone substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infecti …
  • Belize Electricity Ltd:発電所・企業SWOT分析
    Belize Electricity Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • NextEra Energy, Inc. (NEE):企業の財務及び戦略的SWOT分析
    NextEra Energy, Inc. (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Polypipe Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Polypipe Group Mergers and Acqu …
  • Comrod Communication ASA:企業の戦略・SWOT・財務分析
    SummaryComrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Kinross Gold Corp:企業の戦略・SWOT・財務情報
    Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Kinross Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Econergy International plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Econergy International plc Merg …
  • ADP AdvancedMD:(医療機器分野)企業M&A及び提携動向
    Summary ADP AdvancedMD (ADP) is an information technology company. The company develops software solutions to the healthcare market. It offers products and solutions, such as medical billing services, practice management, electronic health records, ePrescribing and cloud platform. ADP’s cloud platfo …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Enzymatica AB (ENZY):企業の財務及び戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a biotechnology company that provides development and marketing of medical products. The company offers products such as mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and dental spr …
  • Surgical Specialties Corporation, Inc.:企業の戦略・SWOT・財務分析
    SummarySurgical Specialties Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Sao Mai – Ben Dinh Petroleum Investment Joint Stock Company (PSB):企業財務及び戦略的SWOT分析
    Summary Sao Mai - Ben Dinh Petroleum Investment Joint Stock Company (PVSB), is an oil and gas company that constructs and maintains infrastructures for petroleum industry. The company provides services such as lease services, construction works for the oil industry, port complex and economic zone op …
  • Nonthavej Hospital Public Co., Ltd. (NTV):企業概要、財務及び戦略的SWOT分析
    Summary Nonthavej Hospital Public Co., Ltd. (Nonthavej) is a healthcare service provider. The hospital provides medical services and out-patient services. Its services include rehabilitation services, physical therapy, traditional medicine, gynecology,sSurgery, internal medicine and pediatrics. Nont …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆